Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8YKD

Cryo-EM structure of ADGRG2-Gs complex with NTF nanobody

Summary for 8YKD
Entry DOI10.2210/pdb8ykd/pdb
EMDB information39365
DescriptorGuanine nucleotide-binding protein G(s) subunit alpha, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, Guanine nucleotide-binding protein subunit gamma, ... (7 entities in total)
Functional Keywordsgpcr, membrane protein
Biological sourceSpodoptera
More
Total number of polymer chains6
Total formula weight233151.75
Authors
Huang, S.M.,Sheng-chao, G. (deposition date: 2024-03-04, release date: 2025-08-13, Last modification date: 2025-10-08)
Primary citationZheng, Y.,Jiang, D.,Lu, Y.,Zhang, C.,Huang, S.M.,Lin, H.,Zhang, D.,Guo, S.,Han, J.,Chen, J.,He, Y.,Zhang, M.,Gao, Y.,Guo, Y.,Wei, R.,Xia, M.,Qin, Y.,Liu, Z.,Yang, F.,Ge, S.,Yi, F.,Yu, X.,Lin, H.,Xiao, P.,Sun, J.P.,Feng, S.
Development of an allosteric adhesion GPCR nanobody with therapeutic potential.
Nat.Chem.Biol., 21:1519-1530, 2025
Cited by
PubMed Abstract: Allosteric modulation of receptor responses to endogenous agonists has therapeutic value, maintaining ligand profiles, reducing side effects and restoring mutant responses. Adhesion G-protein-coupled receptors (aGPCRs), with large N termini, are ideal for allosteric modulator development. We designed a nanobody strategy targeting ADGRG2 N-terminal fragments and got a specific nanobody Nb23-bi, which promoted dehydroepiandrosterone (DHEA)-induced ADGRG2 activation and reversed mutant-induced dysfunctions. By combining structural characterization, crosslinking mass spectrometry, mutational analysis and molecular dynamics simulations, we clarified the allosteric mechanism of how the Nb23-bi modulates conformational changes in the DHEA-binding pocket. Animal studies showed that Nb23-bi promoted the response of DHEA in alleviating testicular inflammation and reversing mutant defects. In summary, we developed an allosteric nanobody of ADGRG2 and gained insights into its functions in reversing disease-associated dysfunctions. Our study may serve as a template for developing allosteric modulators of other aGPCRs for biological and therapeutic purposes.
PubMed: 40374856
DOI: 10.1038/s41589-025-01896-2
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.9 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon